Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.

Avallone G, Margiotta FM, Bombelli A, Gargiulo L, Foti C, Trave I, Rossi M, Magnaterra E, Pigliacelli F, Malagoli P, Giacalone S, Portarapillo A, Patruno C, Schettini N, Bonzano L, Pezzolo E, Chello C, Gori N, Brunasso G, Veronese F, Ortoncelli M, Tolino E, Azzolini A, Bellinato F, Hansel K, Di Brizzi EV, Gurioli C, Esposito M, Giuffrida R, Barei F, Calzari P, Burroni AG, Gola M, Mariano M, Fargnoli MC, Napolitano M, Grieco T, Peris K, Savoia P, Ribero S, Girolomoni G, Stingeni L, Balato A, Costanzo A, Marzano AV, Narcisi A, Ferrucci SM

Open source

DOI
10.1007/s13555-026-01863-2
Published
2026 Sep
Container
Dermatology and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13555-026-01863-2,
  title = {Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.},
  author = {Avallone G and Margiotta FM and Bombelli A and Gargiulo L and Foti C and Trave I and Rossi M and Magnaterra E and Pigliacelli F and Malagoli P and Giacalone S and Portarapillo A and Patruno C and Schettini N and Bonzano L and Pezzolo E and Chello C and Gori N and Brunasso G and Veronese F and Ortoncelli M and Tolino E and Azzolini A and Bellinato F and Hansel K and Di Brizzi EV and Gurioli C and Esposito M and Giuffrida R and Barei F and Calzari P and Burroni AG and Gola M and Mariano M and Fargnoli MC and Napolitano M and Grieco T and Peris K and Savoia P and Ribero S and Girolomoni G and Stingeni L and Balato A and Costanzo A and Marzano AV and Narcisi A and Ferrucci SM},
  year = {2026},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-026-01863-2},
  url = {https://doi.org/10.1007/s13555-026-01863-2}
}

RIS

TY  - JOUR
TI  - Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.
AU  - Avallone G
AU  - Margiotta FM
AU  - Bombelli A
AU  - Gargiulo L
AU  - Foti C
AU  - Trave I
AU  - Rossi M
AU  - Magnaterra E
AU  - Pigliacelli F
AU  - Malagoli P
AU  - Giacalone S
AU  - Portarapillo A
AU  - Patruno C
AU  - Schettini N
AU  - Bonzano L
AU  - Pezzolo E
AU  - Chello C
AU  - Gori N
AU  - Brunasso G
AU  - Veronese F
AU  - Ortoncelli M
AU  - Tolino E
AU  - Azzolini A
AU  - Bellinato F
AU  - Hansel K
AU  - Di Brizzi EV
AU  - Gurioli C
AU  - Esposito M
AU  - Giuffrida R
AU  - Barei F
AU  - Calzari P
AU  - Burroni AG
AU  - Gola M
AU  - Mariano M
AU  - Fargnoli MC
AU  - Napolitano M
AU  - Grieco T
AU  - Peris K
AU  - Savoia P
AU  - Ribero S
AU  - Girolomoni G
AU  - Stingeni L
AU  - Balato A
AU  - Costanzo A
AU  - Marzano AV
AU  - Narcisi A
AU  - Ferrucci SM
PY  - 2026
JO  - Dermatology and therapy
DO  - 10.1007/s13555-026-01863-2
UR  - https://doi.org/10.1007/s13555-026-01863-2
ER  -

APA

G, A., FM, M., A, B., L, G., C, F., I, T., M, R., E, M., F, P., P, M., S, G., A, P., C, P., N, S., L, B., E, P., C, C., N, G., G, B., F, V., M, O., E, T., A, A., F, B., K, H., EV, D. B., C, G., M, E., R, G., F, B., P, C., AG, B., M, G., M, M., MC, F., M, N., T, G., K, P., P, S., S, R., G, G., L, S., A, B., A, C., AV, M., A, N., & SM, F. (2026). Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.. Dermatology and therapy. https://doi.org/10.1007/s13555-026-01863-2

Source records